REPORTS of brain swelling have thrown the safety of Alzheimer's drug Aduhelm into question after the concerning side effect was observed in 41 percent of patients taking the recommended dose. The new findings are being investigated by the FDA.
You Can See More: Alzheimer's disease: Concerns over new drug after brain swelling found in 41% of patients
The following article Alzheimer's disease: Concerns over new drug after brain swelling found in 41% of patients is courtesy of Daily Express :: Health Feed
REPORTS of brain swelling have thrown the safety of Alzheimer's drug Aduhelm into question after the concerning side effect was observed in 41 percent of patients taking the recommended dose. The new findings are being investigated by the FDA.
REPORTS of brain swelling have thrown the safety of Alzheimer's drug Aduhelm into question after the concerning side effect was observed in 41 percent of patients taking the recommended dose. The new findings are being investigated by the FDA.
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.